Investor directory

Alzheimer's Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions and biopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
http://alzdiscovery.org
https://facebook.com/theaddf
https://linkedin.com/company/alzheimer's-drug-discovery-foundation
https://twitter.com/theaddf

Meriel Owen

Director

Past deals in EEG

BrainScope

Series B in 2023
BrainScope, established in 2010, is a medical neurotechnology company based in Bethesda, Maryland. It specializes in developing non-invasive, hand-held medical devices to aid healthcare professionals in rapidly and accurately assessing brain injuries, particularly traumatic brain injuries and concussions. BrainScope's flagship product, BrainScope One, uses electroencephalogram (EEG) signals and advanced algorithms to objectively determine the likelihood and severity of brain injuries, enabling timely and improved patient care. The company serves military markets, emergency departments, pre-hospital/urgent care units, and sports sectors worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.